Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial

Manjula Kurella Tamura(University of California, San Francisco), Daniel E. Weiner(Tufts Medical Center), Tanya R. Gure(The Ohio State University), Jeff D. Williamson(University Memory and Aging Center), Nicholas M. Pajewski(Wake Forest University), Stephen R. Rapp(Wake Forest University), Dena E. Rifkin(University of California San Diego), Mark A. Supiano(Geriatric Research Education and Clinical Center), Anthony A. Killeen(University of Minnesota), Barry I. Freedman(Wake Forest University), Gordon J. Chelune(University of Utah), Suzanne Oparil(University of Alabama at Birmingham), William E. Haley(Jacksonville College), Sarah A. Gaussoin(Wake Forest University)
Journal of the American Society of Nephrology
June 26, 2020
10.1681/asn.2020010038
Cited by 42

Related Papers

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
|JAMA|2013|8k
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|Hypertension|2017|7.4k
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
|Journal of the American College of Cardiology|2017|6.5k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|Hypertension|2017|4.3k